Según un estudio, una sola dosis de un nuevo fármaco antiviral reduce a la mitad el riesgo de enfermarse de COVID grave

Related Posts
Long-Lasting Cardiovascular Burden Seen After COVID-19
February 25, 2022
FRIDAY, Feb. 25, 2022 (HealthDay News) -- The risk and one-year burden of...
Health Highlights: March 10, 2023
March 10, 2023
Poll finds many Americans worried about health care understaffing. Almost 3 out...
AHA News: New Report Details What to Know About Cardiovascular Disease Symptoms
August 18, 2022
THURSDAY, Aug. 18, 2022 (American Heart Association News) -- Symptoms of...
COVID-19 Tied to Higher Risk for New, Worsening Bladder Symptoms
November 7, 2022
MONDAY, Nov. 7, 2022 (HealthDay News) -- COVID-19 infection is associated with...
